// App-Quantinova.ai

1678 : Effective Treatment of Cold Agglutinin Disease/Cold Agglutinin Syndrome with Ibrutinib: An International Case Series

Researchers

Presenter

  • Marit Jalink

Principal Investigators

  • Sigbjrn Berentsen

  • Jorge J. Castillo

  • Steven Treon

  • Bruno Fattizzo

  • Ramona Cassin

  • Masja De Haas

  • Andrea Patriarca

  • Shirley D'Sa

  • Josephine M.I Vos

Medical Centers

  • Center for Clinical Transfusion Research, Sanquin-LUMC, Amsterdam, Netherlands

  • Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway

  • Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA

  • Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA

  • UOC Ematologia, Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico and University of Milan, Milano, Milano, Italy

  • Pediatric Department,Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico,Milano,Italy

  • Department of Urology, Leiden Unviersity Medical Center, Leiden, Netherlands

  • Department of Immunohematology Diagnostics, Sanquin, Amsterdam, Netherlands

  • Division of Hematology, Department of Translation Medicine,Università del Piemonte Orientale,Novara,Italia

  • UCLH Centre for Waldenström's Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust,London,Vereinigtes Königreich

  • Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, Netherlands

Locations

  • Netherlands

  • Norway

  • United States

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Bruton tyrosine kinase

  • Cellular apoptosis susceptibility protein

Drug/Treatment

  • Ibrutinib

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved